Quick Answer
STRATA Skin Sciences, Inc. reported Stockholders Equity of $2.91 million for fiscal year 2025.
STRATA Skin Sciences, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $2.91M | +446.6% |
| 2025 | $532.0K | -82.1% |
| 2025 | $2.98M | -40.1% |
| 2024 | $4.97M | -47.1% |
| 2024 | $9.40M | -1.1% |
| 2024 | $9.51M | +0.8% |
| 2024 | $9.43M | -25.6% |
| 2023 | $12.69M | -41.9% |
| 2022 | $21.83M | -14.1% |
| 2021 | $25.41M | -1.8% |
| 2020 | $25.89M | -9.6% |
| 2019 | $28.65M | -8.3% |
| 2018 | $31.25M | +6.3% |
| 2018 | $29.39M | -4.0% |
| 2018 | $30.60M | +73.7% |
| 2018 | $17.62M | -11.4% |
| 2017 | $19.88M | -4.2% |
| 2017 | $20.75M | +49.8% |
| 2017 | $13.86M | +24.0% |
| 2017 | $11.17M | -25.7% |
| 2016 | $15.04M | -6.5% |
| 2015 | $16.09M | +31.0% |
| 2014 | $12.28M | +48.0% |
| 2013 | $8.30M | -40.6% |
| 2012 | $13.97M | -53.1% |
| 2011 | $29.81M | -6.3% |
| 2010 | $31.80M | +4.9% |
| 2009 | $30.32M | +100.9% |
| 2008 | $15.09M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.31M | -86.0% | +147.0% |
| June 30, 2025 | $532.0K | -94.4% | -82.1% |
| March 31, 2025 | $2.98M | -68.4% | -40.1% |
| December 31, 2024 | $4.97M | -60.8% | -47.1% |
| September 30, 2024 | $9.40M | -41.9% | -1.1% |
| June 30, 2024 | $9.51M | -43.8% | +0.8% |
| March 31, 2024 | $9.43M | -51.2% | -25.6% |
| December 31, 2023 | $12.69M | -41.9% | -21.6% |
- STRATA Skin Sciences, Inc. showed an increase of +446.6% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, STRATA Skin Sciences, Inc.’s stockholders equity has declined by 80.7% (from $15.09 million to $2.91 million).
- The most recent figure is from STRATA Skin Sciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: